AARD News

Pomerantz Law Firm Announces the Filing of a Class Action Against Aardvark Therapeutics, Inc. and Certain Officers and Directors - AARD

AARD Shareholder Alert: Aardvark Therapeutics, Inc. Securities Class Action Lawsuit - Investors With Losses May Contact SueWallSt

Attention Long-Term Shareholders of Aardvark Therapeutics, Inc. (NASDAQ: AARD); Erasca, Inc. (NASDAQ: ERAS); Hub Group, Inc. (NASDAQ: HUBG); and New Era Energy & Digital, Inc. (NASDAQ: NUAI): Grabar Law Office is Investigating Claims on Your Behalf

Aardvark Therapeutics, Inc. (AARD) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of October 13, 2026 Deadline

Recover Investment Losses: Class Action Initiated Against Aardvark Therapeutics, Inc. (AARD)

Lost Money on Aardvark Therapeutics, Inc. (AARD)? Contact Levi & Korsinsky Before October 13, 2026 to Join Class Action

ROSEN, LEADING INVESTOR COUNSEL, Encourages Aardvark Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AARD

Pomerantz LLP Moves to File Class Action Litigation Against Aardvark Therapeutics, Inc. – AARD

Aardvark Therapeutics, Inc. (AARD) Investors with Substantial Losses Have Opportunity to Lead Aardvark Class Action Lawsuit Before October 13 Deadline

AARD INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aardvark Therapeutics, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit!